Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Pancreatic Adenocarcinoma”

286 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 286 results

Testing effectiveness (Phase 2)Study completedNCT00964171
What this trial is testing

Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Institut Bergonié 19
Testing effectiveness (Phase 2)Study completedNCT00735917
What this trial is testing

Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage IV Pancreatic Cancer
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00039403
What this trial is testing

UCN-01 and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT01835041
What this trial is testing

CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more
Wake Forest University Health Sciences 21
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Large-scale testing (Phase 3)Study completedNCT00030732
What this trial is testing

Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Swiss Cancer Institute 319
Early research (Phase 1)UnknownNCT00024063
What this trial is testing

SU006668 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00100815
What this trial is testing

Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Roswell Park Cancer Institute 50
Testing effectiveness (Phase 2)Study completedNCT00005843
What this trial is testing

R115777 in Treating Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Cancer Institute (NCI) 40
Not applicableEnrolling By InvitationNCT07241676
What this trial is testing

Early Recurrence After Surgery for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Recurrent Pancreatic Adenocarcinoma
Azienda Ospedaliera di Padova 500
Testing effectiveness (Phase 2)Study completedNCT01234935
What this trial is testing

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+5 more
Translational Oncology Research International 8
Large-scale testing (Phase 3)Ended earlyNCT00227617
What this trial is testing

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+2 more
University of California, San Francisco 36
Early research (Phase 1)Looking for participantsNCT07227168
What this trial is testing

STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCCNon-Small Cell Lung Cancer NSCLCEsophageal Cancer+6 more
Sutro Biopharma, Inc. 200
Early research (Phase 1)Study completedNCT01131234
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+49 more
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT01064622
What this trial is testing

Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage IV Pancreatic Cancer AJCC v6 and v7
National Cancer Institute (NCI) 118
Large-scale testing (Phase 3)Study completedNCT00024427
What this trial is testing

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganPancreatic Cancer
Wellstat Therapeutics 250
Early research (Phase 1)WithdrawnNCT01741597
What this trial is testing

Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasLiver Metastases+5 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT00429858
What this trial is testing

Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Andrew Ko 21
Early research (Phase 1)Study completedNCT01204476
What this trial is testing

Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma

Who this might be right for
Gastrin-Producing Neuroendocrine TumorLung Carcinoid TumorMetastatic Digestive System Neuroendocrine Tumor G1+12 more
National Cancer Institute (NCI) 27
Early research (Phase 1)Study completedNCT00547612
What this trial is testing

Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
National Institutes of Health Clinical Center (CC) 33
Next Page